Estrogens, progestins, and headache
- PMID: 2046918
- DOI: 10.1212/wnl.41.6.786
Estrogens, progestins, and headache
Abstract
PIP: Migraine headaches appear to be linked to the menstrual cycle and the use of oral contraceptives (OCs). Migraine attacks occur during menses in 60% of women and appear to be related to the withdrawal of estrogen. The fluctuations in estrogen levels associated with migraine headaches produce biochemical changes in prostaglandin production, prolactin release, and opoid regulation. Treatment seeks to interrupt the pathophysiological sequence of menstrual-related migraine through the administration of nonsteroidal anti-inflammatory drugs, ergotamine, or, in refractory cases, hormonal agents. The frequency of migraine decreases with age, but tends either to regress or worsen during menopause. In some cases, estrogen replacement therapy for menopausal symptoms produces headache and it may be necessary to reduce the estrogen dose or change from conjugated estrogen to pure estradiol or estrone. The incidence and severity of migraines are also affected by OC use. OCs may trigger migraine episodes and exacerbate or alleviate pre-existing headache. This variable response seems to be a result of individual differences in intrinsic estrogen neuronal response. Although migraine itself may be a risk factor in stroke, there is no evidence that this risk is increased in migrainers who use OCs.
Similar articles
-
Sex hormones and headache.J Pain Symptom Manage. 1993 Feb;8(2):98-114. doi: 10.1016/0885-3924(93)90107-7. J Pain Symptom Manage. 1993. PMID: 8492007 Review.
-
Sex hormones and headache.Rev Neurol (Paris). 2000;156 Suppl 4:4S30-41. Rev Neurol (Paris). 2000. PMID: 11139745 Review.
-
The role of sex hormones in headache.Neurology. 1992 Mar;42(3 Suppl 2):37-42. Neurology. 1992. PMID: 1557190 Review.
-
Control of fertility with oral medication.West J Surg Obstet Gynecol. 1964 Jul-Aug;72:222-9. West J Surg Obstet Gynecol. 1964. PMID: 12305556
-
Hormonal management of migraine associated with menses and the menopause: a clinical review.Headache. 2007 Feb;47(2):329-40. doi: 10.1111/j.1526-4610.2006.00710.x. Headache. 2007. PMID: 17300386 Review.
Cited by
-
Advances in drug development for acute migraine.Drugs. 2012 Dec 3;72(17):2187-205. doi: 10.2165/11641120-000000000-00000. Drugs. 2012. PMID: 23116251
-
Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses.J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1402-e1412. doi: 10.1210/clinem/dgab868. J Clin Endocrinol Metab. 2022. PMID: 34865056 Free PMC article.
-
Hormonal manipulation strategies in the management of menstrual migraine and other hormonally related headaches.Curr Neurol Neurosci Rep. 2011 Apr;11(2):131-8. doi: 10.1007/s11910-010-0174-7. Curr Neurol Neurosci Rep. 2011. PMID: 21207200
-
Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine.Ther Clin Risk Manag. 2006 Sep;2(3):303-8. doi: 10.2147/tcrm.2006.2.3.303. Ther Clin Risk Manag. 2006. PMID: 18360605 Free PMC article.
-
Unveiling new insights into migraine risk stratification using machine learning models of adjustable risk factors.J Headache Pain. 2025 May 6;26(1):103. doi: 10.1186/s10194-025-02049-5. J Headache Pain. 2025. PMID: 40329184 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical